Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06375720
Other study ID # FujianUTCM-2
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 5, 2024
Est. completion date December 15, 2025

Study information

Verified date April 2024
Source Fujian University of Traditional Chinese Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To determine the relationship between the effects of different frequencies and duration of Tai Chi Chuan in dose parameters to improve cognitive function in elderly persons with mild cognitive impairment.


Description:

Mild cognitive impairment (MCI) is regarded as a prodrome to dementia and affects 16% to 20% of people aged older than 65 years. Tai Chi Chuan is an increasingly popular multi-modal physical and mental exercise. Studies have shown that Tai Chi Chuan can effectively improve the cognitive function of elderly persons with MCI. However, the relationship between the effects of different frequencies and duration of Tai Chi Chuan to improve the cognitive function of elderly persons with MCI is not yet clear. The purpose of this study is to determine the optimal frequency and duration of Tai Chi Chuan. The investigators will conduct a single-blind, randomized controlled trial in 350 persons who meet the presence of MCI without dementia. Persons will be randomly assigned to either the Tai Chi Chuan intervention group once or twice a week for 12 or 24 weeks, or the health education control group once every four weeks for 24 weeks. All groups will be followed for 52 weeks.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 350
Est. completion date December 15, 2025
Est. primary completion date June 15, 2025
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: 1. Presence of mild cognitive impairment, not demented; 2. Age = 60 years old; 3. Informed consent and voluntary participation. Exclusion Criteria: 1. Geriatric Depression Scale score = 9 points; 2. Cognitive impairment caused by other reasons, taking drugs, poisoning, etc; 3. Suffer from severe musculoskeletal system diseases and other contraindications to exercise and are not suitable for Tai Chi Chuan training, such as those who suffer from stroke, Parkinson's disease, and have a history of lower limb arthritis, hip and knee joint replacement, etc; 4. Patients with severe heart, liver, kidney failure, malignant tumors, and other major diseases; 5. Individuals with visual/auditory impairments, writing/reading impairments, illiteracy, etc. that affect training and evaluation; 6. Individuals with uncontrolled hypertension (systolic blood pressure greater than 160mmHg or diastolic blood pressure greater than 100mmHg after medication); 7. Participating in other experiments that influence this study; 8. Engaged in regular exercise in the last three months (at least 3 times a week, at least 20 minutes of regular exercise each time).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Lower frequency, shorter period of Tai Chi Chuan
Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 3 sessions/week for 12 weeks. There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training. Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
Higher frequency, shorter period of Tai Chi Chuan
Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 5 sessions/week for 12 weeks. There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training. Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
Lower frequency, longer period of Tai Chi Chuan
Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 3 sessions/week for 24 weeks. There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training. Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
Higher frequency, longer period of Tai Chi Chuan
Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 5 sessions/week for 24 weeks. There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training. Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
Standard Health Education
Participants would take standard health education 0.5 hour/ session, 2 sessions/month for 6 months.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Lidian Chen Peking University Third Hospital

Outcome

Type Measure Description Time frame Safety issue
Other The Pittsburgh Sleep Quality Index (PSQI) Sleep quality 12 weeks, 24 weeks and 52 weeks
Other 12-Item Short Form Health Survey General health 12 weeks, 24 weeks and 52 weeks
Other Blood glucose metabolism index fasting blood glucose 12 weeks, 24 weeks and 52 weeks
Other Blood lipid metabolism index total cholesterol (TC); total triglyceride (TG); low density lipoprotein (LDL);high density lipoprotein (HDL) 12 weeks, 24 weeks and 52 weeks
Other functional Magnetic Resonance Imaging functional Magnetic Resonance Imaging 12 weeks or 24 weeks [post-intervention]
Other Electroencephalogram The power spectrum density of the brain in a relaxed state is measured using a resting-state electroencephalogram (EEG) for the delta (1-4 Hz), theta (4-8 Hz), alpha (8-13 Hz), beta (13-30 Hz), and gamma (30-100 Hz) bands. 12 weeks or 24 weeks [post-intervention]
Other Heart rate variability Cardiac autonomic modulations 12 weeks or 24 weeks [post-intervention]
Other Gut microflora 16S rRNA amplification sequencing was used to detect intestinal microbiota. 12 weeks, 24 weeks and 52 weeks
Primary Montreal Cognitive Assessment Global cognition 12 weeks, 24 weeks
Secondary Montreal Cognitive Assessment Global cognition 52 weeks
Secondary Wechsler Memory Scale Memory function 12 weeks, 24 weeks and 52 weeks
Secondary Digit Symbol Substitution Test Attention 12 weeks, 24 weeks and 52 weeks
Secondary Trial Making Test part B Executive Function 12 weeks, 24 weeks and 52 weeks
Secondary Stroop Color Word Test Processing Speed 12 weeks, 24 weeks and 52 weeks
Secondary Boston Naming Test Verbal fluency 12 weeks, 24 weeks and 52 weeks
Secondary Rey-Osterrieth Complex Graphics Test Visuo-spatial ability 12 weeks, 24 weeks and 52 weeks
Secondary Rey Auditory Verbal Learning Test Episodic memory 12 weeks, 24 weeks and 52 weeks
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A